Mavrik Dental Systems provides technologies for in-office dental treatment. The company said it will move its commercial operations to the United States following the investment while retaining its product development center in Israel. It raised $30 million in the reported funding round led by Ally Bridge Group. Mavrik's core product focus is on enabling in-office dental procedures through its technology offerings. Ally Bridge Group is a life-science investment firm based in Hong Kong and New York that manages over $2 billion in life science assets. The investment is intended to support Mavrik's commercial expansion into the U.S. market.

Total raised

$30M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2020